← All trials
NCT05182905
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 9, 2022
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2025
- First posted
- Jan 10, 2022
- Last posted
- Mar 25, 2022
- Enrollment
- 21
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ArizonaLead sponsor
- AstraZenecaCollaborator
- University of ArizonaSponsor investigator
- Barrow Neurological InstituteCollaborator
- Ivy Brain Tumor CenterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.